TENNI, RUGGERO
 Distribuzione geografica
Continente #
NA - Nord America 1.577
EU - Europa 1.168
AS - Asia 788
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 4
AF - Africa 3
OC - Oceania 2
Totale 3.548
Nazione #
US - Stati Uniti d'America 1.573
CN - Cina 713
IE - Irlanda 376
UA - Ucraina 210
FI - Finlandia 152
IT - Italia 123
DE - Germania 110
SE - Svezia 64
GB - Regno Unito 60
SG - Singapore 46
BE - Belgio 28
FR - Francia 25
JP - Giappone 12
IR - Iran 11
RU - Federazione Russa 10
A2 - ???statistics.table.value.countryCode.A2??? 5
CA - Canada 4
CZ - Repubblica Ceca 3
MU - Mauritius 3
AU - Australia 2
BR - Brasile 2
IN - India 2
NL - Olanda 2
RO - Romania 2
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
MD - Moldavia 1
MY - Malesia 1
TR - Turchia 1
Totale 3.548
Città #
Dublin 376
Chandler 370
Jacksonville 236
Nanjing 184
Ann Arbor 120
Beijing 115
Ashburn 102
Boardman 93
Nanchang 78
Shenyang 69
Lawrence 57
Medford 57
Princeton 57
Changsha 54
Wilmington 54
Hebei 43
Helsinki 41
Shanghai 39
Tianjin 36
Jiaxing 32
Milan 31
Pavia 30
Hangzhou 29
Woodbridge 29
Brussels 28
Singapore 26
Verona 19
Los Angeles 15
New York 12
Fairfield 9
Norwalk 9
Washington 9
Auburn Hills 8
Dearborn 8
Houston 8
Tokyo 8
Chicago 6
Ningbo 6
Ardabil 5
Des Moines 5
Falkenstein 5
Munich 5
Seattle 5
Changchun 4
Jinan 4
Zanjan 4
Brno 3
Dallas 3
Duncan 3
Falls Church 3
Monmouth Junction 3
San Giuliano Milanese 3
St Petersburg 3
Zhengzhou 3
Andover 2
Augusta 2
Bologna 2
Brugherio 2
Cambridge 2
Kunming 2
Maranello 2
Nakano 2
Pune 2
Tappahannock 2
Teano 2
Toronto 2
Austin 1
Baku 1
Berlin 1
Borås 1
Chisinau 1
Council Bluffs 1
Cupertino 1
Edmonton 1
Ercolano 1
Gazipur 1
Genova 1
Guangzhou 1
Kuala Lumpur 1
Lincoln 1
Logan 1
Montereale Valcellina 1
Moscow 1
Orange 1
Ottawa 1
Piscataway 1
Reghin 1
Sacramento 1
Southend 1
Taganrog 1
Taizhou 1
Tirana 1
Torre del Greco 1
Voronezh 1
Totale 2.616
Nome #
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 106
Conformational analysis and stability of collagen peptides by CD and by 1H- and 13C-NMR spectroscopies. 94
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 92
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 90
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 86
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 81
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 80
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 77
Platelet interaction with CNBr peptides from type II collagen via integrin alpha2 beta1 77
Extracellular matrix structure and nano-mechanics determine megakaryocyte function 76
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 75
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 75
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 75
Collagen fibril structure is affected by collagen concentration and decorin 74
Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. 74
Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms. 72
A Mn(II)-Mn(II) center in human prolidase 72
A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. 71
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 71
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 69
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 68
Lack of prolidase causes a bone phenotype both in human and in mouse 66
Stability of type I collagen peptide trimers. 64
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 64
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity. 64
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 64
Fibromodulin interactions with type I and II collagens. 63
The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. 63
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 63
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 63
Effect of an oral calcium load on urinary markers of collagen breakdown. 62
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 60
Hypothesis on the role of hydroxylysyl glycosides in collagen fibre organization. 59
Osteogenesis imperfecta mutations may probe vital functional domains (e.g. proteoglycan binding sites) of type I collagen fibrils. 58
EXTRACELLULAR MATRIX NANO-MECHANICS DETERMINE MEGAKARYOCITE FUNCTION. 58
Extracellular matrix nano-mechanics determines megakaryocyte function 58
Type I collagen CNBr peptides: species and behavior in solution 56
Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17b-estradiol replacement in aged rats. 55
Mapping Hsp47-binding site(s) using CNBr peptides derived from type I and II collagen 54
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 54
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 52
Prolidase deficiency in two siblings with chronic leg ulcerations. Clinical, biochemical, and morphologic aspects. 52
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 52
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 52
Pre-column derivatisation method for the measurement of glycosylated hydroxylysines of collagenous proteins. 51
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 50
Calorimetric, biochemical and morphological investigations to validate a restoration method of fire injured ancient parchment. 50
Identifying the structure of the active sites of human recombinant prolidase 49
Gly85 to Val substitution in proa1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion. 48
Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. 47
Molecular stability of chemically modified collagen triple helices 47
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 46
"In vitro" fibril formation of type I collagen from different sources: biochemical and morphological aspects. 45
The structure of extracellular matrices influences proplatelet formation by human megakaryocyte 42
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine a1(I) 901 substitution in a type-I collagen gene. 40
Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. 38
Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen. 36
Totale 3.600
Categoria #
all - tutte 13.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 0 0 0 0 3 40 7 55 7 86 74 0
2020/2021371 52 35 9 42 2 42 7 58 12 53 48 11
2021/2022299 9 4 11 9 6 4 8 16 17 11 52 152
2022/20231.012 84 97 7 81 106 99 1 62 419 8 25 23
2023/2024363 52 69 13 29 28 88 13 23 4 13 14 17
2024/2025146 33 70 28 15 0 0 0 0 0 0 0 0
Totale 3.600